Viracta Therapeutics, Inc. (VIRX) Misses Q4 EPS by 4c
Tweet
Share
E-mailGet Alerts VIRX Hot Sheet
Join SI Premium – FREE
Viracta Therapeutics, Inc. (NASDAQ: VIRX) reported Q4 EPS of ($0.35), $0.04 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Viracta Therapeutics, Inc. (VIRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
- Momo (MOMO) Tops Q2 EPS by 8c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
